## AME: AMETEK, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 2.7% below STRENGTH zone (4.0-10.0%); PEG 2.73 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($199.54)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Voya Investment Management LLC Sells 22,980 Shares of AMETEK, Inc. $AME**
- Source: MarketBeat | 20251222T125504 | Somewhat-Bullish | Relevance: 100%
- Voya Investment Management LLC decreased its stake in AMETEK, Inc. (NYSE:AME) by 15.4% in the third quarter, selling 22,980 shares and leaving them with 126,070 shares valued at $23.7 million. Despite this, other institutional investors have increased their holdings, and analysts maintain a "Moderate Buy" rating for AMETEK with an average price target of $212.00. The company recently reported strong Q3 earnings and announced a quarterly dividend.

**2. CCLA Investment Management Grows Position in AMETEK, Inc. $AME**
- Source: MarketBeat | 20251222T100857 | Somewhat-Bullish | Relevance: 100%
- CCLA Investment Management has increased its stake in AMETEK, Inc. (NYSE:AME) by 9.1%, bringing their total to 258,653 shares valued at approximately $48.6 million, as institutional investors now hold a significant 87.43% of the company's stock. This increase comes after AMETEK surpassed its Q3 earnings estimates, reporting $1.89 EPS and $1.89 billion in revenue, and subsequently issued strong FY2025 guidance. Despite recent insider selling, analysts maintain a "Moderate Buy" rating with a $212 price target, reflecting continued confidence in the technology company.

**3. AMETEK, Inc. $AME Shares Acquired by L. Roy Papp & Associates LLP**
- Source: MarketBeat | 20251220T121143 | Somewhat-Bullish | Relevance: 100%
- L. Roy Papp & Associates LLP increased its stake in AMETEK, Inc. by 17.7% during the third quarter, bringing their total holdings to 43,688 shares valued at $8.21 million. This comes amidst insider selling from executives Ronald J. Oscher and CEO David A. Zapico, who sold a combined total of over $10 million in shares recently. AMETEK, Inc. has shown strong financial performance, beating Q3 earnings estimates and issuing positive FY2025 guidance, maintaining a "Moderate Buy" consensus rating among analysts.

**4. Inside the custom elevators powering Montreal's new driverless metro**
- Source: Stock Titan | 20251222T123249 | Somewhat-Bullish | Relevance: 63%
- Otis (NYSE: OTIS) has completed a significant installation for Montreal's Réseau Express Métropolitain (REM) light metro, providing 57 custom elevators and 22 escalators across the 67 km, 26-station network. These systems include energy-efficient ReGen drives and custom integrations for real-time monitoring and automated evacuation, along with accessibility features. Otis also secured a five-year service contract for maintenance, reinforcing its role in major transit infrastructure projects.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | DA Davidson | $240 | $235 | +2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | DA Davidson | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.91M) |
| Sells | 4 ($7.72M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (+0.6%)
- Blackrock Inc.: 8.5% (-0.9%)
- Price (T.Rowe) Assoc: 4.3% (-7.3%)
- State Street Corpora: 4.2% (+1.3%)
- JPMORGAN CHASE & CO: 3.6% (+77.0%)

### Key Risks

1. Insider selling cluster: $7.7M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.73 signals overvaluation risk, limited margin of safety. Forward P/E 25.9x stretched relative to 8% growth. Quality metrics strong (margin 20%). Insider selling cluster ($7.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $47.6B |
| Beta | 1.05 |
| 52W Range | $145.02 - $206.37 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.73 |
| Forward P/E | 25.9 |
| Current P/E | 28.1 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 2.7% (minimal 5-day change). Below STRENGTH zone by 1.3pp (needs >4.0% for momentum thesis). MRS_5 at 0.4% confirms short-term momentum alignment. AM_20 at 3.3% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.67% (CS: 71) | Neutral |
| RSI_14 | 64.4 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 1.131x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $206.20
- **Stop Loss:** $199.54 (3.2% risk)
- **Target:** $212.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 135
- **Position Value:** $27,837.00
- **Portfolio %:** 27.84%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-03 (Est: $1.94)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.76 | $1.89 | +7.4% |
| 2025Q2 | $1.69 | $1.78 | +5.5% |
| 2025Q1 | $1.69 | $1.75 | +3.5% |
| 2024Q4 | $1.85 | $1.87 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*